Cargando…

Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity

BACKGROUND: Asthma prevalence among COVID-19 patients seems to be surprisingly low. However the clinical profile of COVID-19 asthmatic patients and potential determinants of higher susceptibility/worse outcome have been scarcely investigated. We aimed to describe the prevalence and features of asthm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caminati, Marco, Vultaggio, Alessandra, Matucci, Andrea, Senna, Gianenrico, Almerigogna, Francesco, Bagnasco, Diego, Chieco-Bianchi, Fulvia, Cosini, Filippo, Girelli, Domenico, Guarnieri, Gabriella, Menzella, Francesco, Micheletto, Claudio, Olivieri, Oliviero, Passalacqua, Gianni, Pini, Laura, Rossi, Oliviero, Vianello, Andrea, Vivarelli, Emanuele, Crisafulli, Ernesto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688414/ https://www.ncbi.nlm.nih.gov/pubmed/33260107 http://dx.doi.org/10.1016/j.rmed.2020.106261

Ejemplares similares

COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control
por: Caminati, Marco, et al.
Publicado: (2021)

Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient
por: Guarnieri, Gabriella, et al.
Publicado: (2022)

Asthmatic patients in COVID-19 outbreak: Few cases despite many cases
por: Caminati, Marco, et al.
Publicado: (2020)

Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry
por: Caminati, Marco, et al.
Publicado: (2022)

Relative Humidity and Its Impact on the Immune System and Infections
por: Guarnieri, Gabriella, et al.
Publicado: (2023)

Targeting eosinophils: severe asthma and beyond
por: Caminati, Marco, et al.
Publicado: (2019)

Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
por: Caminati, Marco, et al.
Publicado: (2021)

Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance
por: Caminati, Marco, et al.
Publicado: (2023)

Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19
por: Bruno, Chiara, et al.
Publicado: (2020)

Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach
por: Maule, Matteo, et al.
Publicado: (2023)

Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
por: Caminati, M., et al.
Publicado: (2016)

Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
por: Guarnieri, Gabriella, et al.
Publicado: (2022)

Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective
por: Caminati, Marco, et al.
Publicado: (2023)

Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics
por: Caminati, Marco, et al.
Publicado: (2020)

New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
por: Caminati, Marco, et al.
Publicado: (2019)

Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly
por: Scichilone, Nicola, et al.
Publicado: (2015)

Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses
por: Vianello, Andrea, et al.
Publicado: (2021)

The intriguing possibility of using probiotics in allergen-specific immunotherapy
por: Furci, Fabiana, et al.
Publicado: (2023)

Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19
por: Dorelli, Gianluigi, et al.
Publicado: (2021)

COVID-19: general overview, pharmacological options and ventilatory support strategies
por: Menzella, Francesco, et al.
Publicado: (2020)

Uncontrolled Asthma: Unmet Needs in the Management of Patients
por: Caminati, Marco, et al.
Publicado: (2021)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021)

Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis
por: Vultaggio, Alessandra, et al.
Publicado: (2020)

Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience
por: Matucci, Andrea, et al.
Publicado: (2022)

EGPA Phenotyping: Not Only ANCA, but Also Eosinophils
por: Matucci, Andrea, et al.
Publicado: (2023)

A Survey of Clinical Features of Allergic Rhinitis in Adults
por: Frati, Franco, et al.
Publicado: (2014)

The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19
por: Furci, Fabiana, et al.
Publicado: (2021)

Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study
por: Vultaggio, Alessandra, et al.
Publicado: (2020)

Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy
por: Tognella, Silvia, et al.
Publicado: (2021)

Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19
por: Ageno, Walter, et al.
Publicado: (2021)

Cytomegalovirus-Induced Gastrointestinal Bleeding and Pancreatitis Complicating Severe Covid-19 Pneumonia: A Paradigmatic Case
por: Marchi, Giacomo, et al.
Publicado: (2020)

Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study
por: Crisafulli, Ernesto, et al.
Publicado: (2021)

Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19
por: Righi, Elda, et al.
Publicado: (2021)

Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges?
por: Benoni, Roberto, et al.
Publicado: (2022)

Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele
por: Olivieri, Oliviero, et al.
Publicado: (2013)

Quick Olfactory Sniffin’ Sticks Test (Q-Sticks) for the detection of smell disorders in COVID-19 patients
por: Bagnasco, Diego, et al.
Publicado: (2021)

Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out
por: De Franceschi, Lucia, et al.
Publicado: (2020)

Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors
por: Matucci, Andrea, et al.
Publicado: (2021)

Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy
por: Caminati, Marco, et al.
Publicado: (2019)

Upsides and downsides of a telecounselling model of integrated asthma management between general practitioners and specialists
por: Furci, Fabiana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ls9so11jenflk1a92aj4n39ktm